Yaqing Dai

437 total citations
15 papers, 319 citations indexed

About

Yaqing Dai is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yaqing Dai has authored 15 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yaqing Dai's work include Peptidase Inhibition and Analysis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Yaqing Dai is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Yaqing Dai collaborates with scholars based in China and Singapore. Yaqing Dai's co-authors include Qin Lin, Long Sun, Haojun Chen, Liang Zhao, Hua Wu, Yizhen Pang, Jiancheng Li, Xiurong Wu, Dan Ruan and Wei Guo and has published in prestigious journals such as Clinical Cancer Research, Medicine and Radiotherapy and Oncology.

In The Last Decade

Yaqing Dai

13 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaqing Dai China 7 275 176 147 53 45 15 319
İhsan Kaplan Türkiye 8 240 0.9× 122 0.7× 147 1.0× 76 1.4× 35 0.8× 27 282
Havva Yeşil Çınkır Türkiye 8 138 0.5× 84 0.5× 72 0.5× 59 1.1× 39 0.9× 32 249
Aydın Aytekin Türkiye 8 197 0.7× 69 0.4× 102 0.7× 48 0.9× 45 1.0× 25 259
Özlem Nuray Sever Türkiye 9 204 0.7× 87 0.5× 92 0.6× 61 1.2× 51 1.1× 38 278
Hong Grafe Germany 7 171 0.6× 103 0.6× 63 0.4× 121 2.3× 22 0.5× 17 262
Eleni Mavriopoulou Germany 7 356 1.3× 118 0.7× 113 0.8× 172 3.2× 101 2.2× 10 471
Miriam Sraieb Germany 9 98 0.4× 46 0.3× 61 0.4× 131 2.5× 59 1.3× 15 231
F Robiller Germany 4 283 1.0× 121 0.7× 58 0.4× 117 2.2× 23 0.5× 10 364
Reid Perlman United States 5 98 0.4× 141 0.8× 144 1.0× 55 1.0× 177 3.9× 6 376
Hideyo Kimura Japan 13 339 1.2× 313 1.8× 59 0.4× 11 0.2× 145 3.2× 25 443

Countries citing papers authored by Yaqing Dai

Since Specialization
Citations

This map shows the geographic impact of Yaqing Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqing Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqing Dai more than expected).

Fields of papers citing papers by Yaqing Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaqing Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqing Dai. The network helps show where Yaqing Dai may publish in the future.

Co-authorship network of co-authors of Yaqing Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yaqing Dai. A scholar is included among the top collaborators of Yaqing Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaqing Dai. Yaqing Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhao, Liang, Yizhen Pang, Yi Ding, et al.. (2025). 68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study. Clinical Cancer Research. 31(14). 2989–3001. 3 indexed citations
2.
Dai, Yaqing, et al.. (2025). Induction Camrelizumab and Modified TPF (Nab‐Paclitaxel, Cisplatin, and S‐1) in Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer Science. 116(6). 1616–1626. 1 indexed citations
3.
Chen, Jianhao, Yaqing Dai, Yangfan Zhou, et al.. (2024). Enhanced Detection of Early Pulmonary Fibrosis Disease Using 68Ga-FAPI-LM3 PET. Molecular Pharmaceutics. 21(7). 3684–3692. 3 indexed citations
4.
Xie, Wenhui, et al.. (2024). Influencing and Prognostic Factors of End-Stage Hypertrophic Cardiomyopathy. ESC Heart Failure. 11(6). 4028–4037. 1 indexed citations
5.
6.
Zhao, Liang, Peiqiong Chen, Kaili Fu, et al.. (2021). Concordance of PD-L1 Status Between Image-Guided Percutaneous Biopsies and Matched Surgical Specimen in Non-Small Cell Lung Cancer. Frontiers in Oncology. 10. 551367–551367. 7 indexed citations
7.
Zhao, Liang, Shanyu Chen, Sijia Chen, et al.. (2021). 68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer. Radiotherapy and Oncology. 158. 55–61. 40 indexed citations
8.
Lin, Qin, Jun Liu, K. C. Chu, et al.. (2020). Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses. Cancer Medicine. 9(18). 6524–6532. 20 indexed citations
9.
Li, Jinluan, et al.. (2020). Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma. Translational Oncology. 14(1). 100956–100956. 1 indexed citations
10.
Chen, Haojun, Liang Zhao, Dan Ruan, et al.. (2020). Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 73–86. 172 indexed citations
11.
12.
Dai, Yaqing, et al.. (2019). Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy. Annals of Translational Medicine. 7(8). 175–175. 24 indexed citations
13.
14.
Li, Tingting, et al.. (2019). The long-term impact of tumor burden in pT3N0M0 esophageal squamous cell carcinoma. Medicine. 98(42). e17637–e17637. 3 indexed citations
15.
Ling, Xuefeng B., et al.. (2011). P46 Adverse events of nimotuzumab combination therapy in patients with advanced carcinoma. European Journal of Cancer Supplements. 9(1). 18–19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by İhsan Kaplan Breakdown of academic impact, for papers by Havva Yeşil Çınkır Breakdown of academic impact, for papers by Aydın Aytekin Breakdown of academic impact, for papers by Özlem Nuray Sever Breakdown of academic impact, for papers by Hong Grafe Breakdown of academic impact, for papers by Eleni Mavriopoulou Breakdown of academic impact, for papers by Miriam Sraieb Breakdown of academic impact, for papers by F Robiller Breakdown of academic impact, for papers by Reid Perlman Breakdown of academic impact, for papers by Hideyo Kimura
Rankless by CCL
2026